BNP Paribas Financial Markets’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2M | Sell |
40,497
-107,222
| -73% | -$5.44M | ﹤0.01% | 2797 |
|
|
2026
Q1 | $7.88M | Sell |
147,719
-104,810
| -42% | -$6.15M | ﹤0.01% | 1709 |
|
|
2025
Q4 | $15.7M | Buy |
252,529
+242,966
| +2,541% | +$15M | 0.01% | 1334 |
|
|
2025
Q3 | $575K | Sell |
9,563
-145,972
| -94% | -$8.93M | ﹤0.01% | 3473 |
|
|
2025
Q2 | $9.74M | Sell |
155,535
-98,526
| -39% | -$5.92M | 0.01% | 1461 |
|
|
2025
Q1 | $15.3M | Sell |
254,061
-94,251
| -27% | -$5.85M | 0.01% | 1173 |
|
|
2024
Q4 | $20.3M | Buy |
348,312
+191,921
| +123% | +$11.4M | 0.01% | 1016 |
|
|
2024
Q3 | $9.26M | Sell |
156,391
-194,352
| -55% | -$11.1M | 0.01% | 1202 |
|
|
2024
Q2 | $19.7M | Buy |
350,743
+234,573
| +202% | +$13.1M | 0.02% | 784 |
|
|
2024
Q1 | $6.81M | Buy |
116,170
+99,118
| +581% | +$5.6M | 0.01% | 1263 |
|
|
2023
Q4 | $920K | Sell |
17,052
-30,574
| -64% | -$1.49M | ﹤0.01% | 2433 |
|
|
2023
Q3 | $2.31M | Buy |
47,626
+30,363
| +176% | +$1.61M | ﹤0.01% | 1789 |
|
|
2023
Q2 | $975K | Sell |
17,263
-25,960
| -60% | -$1.43M | ﹤0.01% | 2217 |
|
|
2023
Q1 | $2.33M | Buy |
43,223
+14,846
| +52% | +$790K | ﹤0.01% | 1717 |
|
|
2022
Q4 | $1.49M | Buy |
28,377
+5,004
| +21% | +$254K | ﹤0.01% | 1936 |
|
|
2022
Q3 | $1.1M | Buy |
23,373
+13,466
| +136% | +$699K | ﹤0.01% | 2407 |
|
|
2022
Q2 | $500K | Sell |
9,907
-19,604
| -66% | -$1.07M | ﹤0.01% | 2653 |
|
|
2022
Q1 | $1.8M | Buy |
29,511
+1,867
| +7% | +$111K | ﹤0.01% | 1902 |
|
|
2021
Q4 | $1.82M | Buy |
27,644
+3,620
| +15% | +$232K | ﹤0.01% | 2124 |
|
|
2021
Q3 | $1.51M | Sell |
24,024
-2,694
| -10% | -$172K | ﹤0.01% | 2096 |
|
|
2021
Q2 | $1.61M | Buy |
26,718
+1,938
| +8% | +$112K | ﹤0.01% | 1874 |
|
|
2021
Q1 | $1.36M | Buy |
24,780
+5,814
| +31% | +$322K | ﹤0.01% | 1947 |
|
|
2020
Q4 | $1.03M | Sell |
18,966
-300,276
| -94% | -$15.7M | ﹤0.01% | 2003 |
|
|
2020
Q3 | $15.9M | Buy |
319,242
+810
| +0.3% | +$39.2K | 0.02% | 601 |
|
|
2020
Q2 | $14.1M | Buy |
318,432
+315,840
| +12,185% | +$13.5M | 0.02% | 582 |
|
|
2020
Q1 | $97.4K | Sell |
2,592
-2,574
| -50% | -$108K | ﹤0.01% | 3228 |
|
|
2019
Q4 | $228K | Buy |
5,166
+4,800
| +1,311% | +$202K | ﹤0.01% | 2895 |
|
|
2019
Q3 | $15.1K | Sell |
366
-132
| -27% | -$5.4K | ﹤0.01% | 4058 |
|
|
2019
Q2 | $20K | Buy |
+498
| New | +$18.8K | ﹤0.01% | 3893 |
|
|
2015
Q2 | – | Sell |
-705,000
| Closed | -$14.1M | – | 3578 |
|
|
2015
Q1 | $14.1M | Buy |
+705,000
| New | +$13.8M | 0.04% | 301 |
|
|
2014
Q4 | – | Sell |
-49,800
| Closed | -$825K | – | 2562 |
|
|
2014
Q3 | $825K | Sell |
49,800
-63,390
| -56% | -$1.08M | ﹤0.01% | 1330 |
|
|
2014
Q2 | $1.92M | Buy |
+113,190
| New | +$1.85M | ﹤0.01% | 970 |
|
Other funds holding IHI
AAS
BNP Paribas Financial Markets's IHI Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its iShares US Medical Devices ETF (IHI) stake by 73% in Q2 2026, selling an estimated $5.44M and leaving 40,497 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2797.
BNP Paribas Financial Markets first reported a position in IHI in Q2 2014 and has held it in 32 quarters since. The position peaked at $20.3M in Q4 2024. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- BNP Paribas Financial Markets held 40,497 shares of iShares US Medical Devices ETF worth $2M as of Q2 2026.
- BNP Paribas Financial Markets sold 107,222 iShares US Medical Devices ETF shares in Q2 2026, an estimated $5.44M.
- iShares US Medical Devices ETF made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2797 holding.
- BNP Paribas Financial Markets first reported a position in iShares US Medical Devices ETF in Q2 2014 and has held it in 32 quarters since.
- BNP Paribas Financial Markets's iShares US Medical Devices ETF position peaked at $20.3M in Q4 2024.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.